Drug Trial Radar · NCT01307267
A Study Of PF-05082566 As A Single Agent And In Combination With Rituximab
Last checked: Nov 19, 2026Latest source record: Mar 17, 2020 (this record)Source: ClinicalTrials.govMethods & limitations
Status
Completed
Enrollment
190
Actual
Start
Jun 21, 2011
Primary completion
Feb 20, 2019
Study completion Feb 20, 2019
Sponsor
- Lead sponsor
- PfizerPfizer (PFE)
- Sponsor type
- Industry
- First posted
- Mar 2, 2011
Design
- Study type
- Interventional
- Phase
- Phase 1
- Allocation
- Non randomized
- Model
- Parallel
- Masking
- None
- Primary purpose
- Treatment
- Who can join
- All sexes, from 18 years
- Healthy volunteers
- No
Summary
As written by the sponsor on the registry.
A study of PF-05082566, a 4-1BB agonist monoclonal antibody (mAb), in patients with solid tumors or b-cell lymphomas, and in combination with rituximab in patients with CD20 positive Non-Hodgkin's Lymphoma (NHL).
Conditions
- Lymphoma, Non-Hodgkin
- Lymphoma, Follicular
- Lymphoma, Large B-Cell, Diffuse
- Carcinoma, Non-Small-Cell Lung
- Carcinoma, Renal Cell
- Carcinoma, Squamous Cell of Head and Neck
- Malignant Melanoma
Interventions
PF-05082566Drug
Intravenous, Dose escalation, once per month
rituximabDrug
Intravenous, 375 mg/m2, once per week for 4 weeks
PF-05082566Drug
IV, Dose escalation, once per month
Primary outcomes
What the sponsor says the trial is designed to measure.
- Number of Participants With Dose-Limiting Toxicities (DLTs) in First 2 Cycles of Portion ATime frame: Cycle 1 Day 1 to Cycle 2 Day 29 in Portion A (up to 57 days, each cycle = 28 days)
- Number of Participants With DLTs in First 2 Cycles of Portion BTime frame: Cycle 1 Day 1 to Cycle 2 Day 29 in Portion B (up to 57 days, each cycle = 28 days)
Locations
42 sites in 5 countries. Site status is shown where the registry gives one.
City of Hope
Duarte, California
UC San Diego Moores Cancer Center-Investigational Drug Services
La Jolla, California
UC San Diego Medical Center-La Jolla (Jacobs Medical Center/Thornton Hospital)
La Jolla, California
UC San Diego Moores Cancer Center
La Jolla, California
Research Administration Office: Clinical Research Unit
Los Angeles, California
Ronald Reagan UCLA Medical Center, Drug Information Center
Los Angeles, California
UCLA Bowyer Clinic
Los Angeles, California
UCLA Hematology-Oncology Clinic
Los Angeles, California
Stanford University Medical Center
Palo Alto, California
Stanford University Medical Center
Palo Alto, California
UC San Diego Medical Center - Hillcrest
San Diego, California
Santa Monica UCLA Hematology & Oncology Clinic
Santa Monica, California
Stanford University Medical Center
Stanford, California
Georgetown University Medical Center Department of Pharmacy, Research
Washington D.C., District of Columbia
MedStar Georgetown University Hospital
Washington D.C., District of Columbia
Emory University Hospital Midtown
Atlanta, Georgia
Emory University Hospital
Atlanta, Georgia
The Emory Clinic, Building A
Atlanta, Georgia
The Emory Clinic
Atlanta, Georgia
Winship Cancer Institute
Atlanta, Georgia
Brigham and Woman's Hospital
Boston, Massachusetts
Dana-Farber Cancer Institute
Boston, Massachusetts
University of Michigan Health System
Ann Arbor, Michigan
Siteman Cancer Center - St. Peters
City of Saint Peters, Missouri
Siteman Cancer Center-West County
Creve Coeur, Missouri
Barnes-Jewish Hospital
St Louis, Missouri
Barnes-Jewish Hospital
St Louis, Missouri
Washington University Infusion Center Pharmacy
St Louis, Missouri
Washington University School of Medicine
St Louis, Missouri
Siteman Cancer Center- South County
St Louis, Missouri
Memorial Sloan Kettering Cancer Center
New York, New York
The University of Texas - M.D. Anderson Cancer Center
Houston, Texas
South Texas Accelerated Research Therapeutics, LLC
San Antonio, Texas
Seattle Cancer Care Alliance
Seattle, Washington
University of Washington Medical Center
Seattle, Washington
Peter MacCallum Cancer Centre
Melbourne, Victoria, Australia
Centre d'investigation clinique
Rennes, France
Az. Ospedaliera-Univer. di Bologna Policlinico S. Orsola Malpighi
Bologna, BO, Italy
Ospedale San Raffaele di Milano
Milan, MI, Italy
Akita University Hospital
Akita, Japan
Showing 40 of 42 sites, US sites first. The full list is on the registry record.
Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.
For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.